Dr Reddys Laboratories (RDY) Receivables - Other (2017 - 2025)

Dr Reddys Laboratories (RDY) has 6 years of Receivables - Other data on record, last reported at $96332.4 in Q1 2024.

  • For Q1 2024, Receivables - Other fell 1.01% year-over-year to $96332.4; the TTM value through Mar 2024 reached $96332.4, down 1.01%, while the annual FY2024 figure was $96640.8, 3.08% down from the prior year.
  • Receivables - Other reached $96332.4 in Q1 2024 per RDY's latest filing, down from $97318.8 in the prior quarter.
  • Across five years, Receivables - Other topped out at $548595.0 in Q1 2021 and bottomed at $96332.4 in Q1 2024.
  • Average Receivables - Other over 4 years is $318552.3, with a median of $314640.9 recorded in 2022.
  • Peak YoY movement for Receivables - Other: crashed 81.71% in 2023, then fell 1.01% in 2024.
  • A 4-year view of Receivables - Other shows it stood at $548595.0 in 2021, then dropped by 3.03% to $531962.9 in 2022, then plummeted by 81.71% to $97318.8 in 2023, then dropped by 1.01% to $96332.4 in 2024.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $96332.4 in Q1 2024, $97318.8 in Q1 2023, and $531962.9 in Q1 2022.